XML 49 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2025
Summary of Financial Items Carried at Fair Value
Financial items carried at fair value on a recurring basis as of March 31, 2025 and December 31, 2024 are classified in the tables below in one of the three categories of fair value levels:
 
    
March 31, 2025
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(U.S. $ in millions)
 
Cash and cash equivalents:
           
Money markets
   $ 1,168      $ —       $ —       $ 1,168  
Cash, deposits and other
     529        —         —         529  
Investment in securities:
           
Equity securities
     10        —         —         10  
Other
     6        —         —         6  
Derivatives:
           
Asset derivatives:
           
Options and forward contracts
     —         27        —         27  
Liability derivatives:
           
Options and forward contracts
     —         (72      —         (72
Bifurcated embedded derivatives
     —         —         §        —   
Contingent consideration*
     —         —         (394      (394
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,713      $ (46    $ (394    $ 1,274  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2024
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(U.S. $ in millions)
 
Cash and cash equivalents:
           
Money markets
   $ 2,005      $ —       $ —       $ 2,005  
Cash, deposits and other
     1,295        —         —         1,295  
Investment in securities:
           
Equity securities
     12        —         —         12  
Other
     3        —         —         3  
Derivatives:
           
Asset derivatives:
           
Options and forward contracts
     —         71        —         71  
Liability derivatives:
           
Options and forward contracts
     —         (24      —         (24
Bifurcated embedded derivatives
     —         —         §        —   
Contingent consideration*
   $ —         —         (401      (401
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
     3,315      $ 47      $ (401    $ 2,961  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
§
Represents an amount less than $0.5 million.
*
Contingent consideration represents liabilities recorded at fair value in connection with acquisitions.
Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs
The following table summarizes the activity for the financial assets and liabilities where fair value measurements are estimated utilizing Level 3 inputs:
 
    
Three months

ended March 31,

2025
    
Three months

ended March 31,

2024
 
    
(U.S. $ in millions)
 
Fair value at the beginning of the period
   $ (401      (477
Bifurcated embedded derivatives
     §        §  
Adjustments to provisions for contingent consideration:
     
Allergan transaction
     (9      (64
Eagle transaction
     (1      (14
Novetide transaction
     (1      (1
Settlement of contingent consideration:
     
Allergan transaction
     4        13  
Eagle transaction
     12        15  
Novetide transaction
     2        1  
  
 
 
    
 
 
 
Fair value at the end of the period
   $ (394    $ (527
  
 
 
    
 
 
 
 
§
Represents an amount less than $0.5 million.
Summary of Financial Instrument Measured on a Basis Other Than Fair Value
Financial instruments measured on a basis other than fair value mostly consist of senior notes, sustainability-linked senior notes and convertible senior debentures (see note 7) and are presented in the table below in terms of fair value (level 1 inputs):
 
    
Estimated fair value*
 
    
March 31,
2025
    
December 31,
2024
 
    
(U.S. $ in millions)
 
Senior notes and sustainability-linked senior notes included under senior notes and loans
   $ 15,938      $ 15,717  
Senior notes and convertible senior debentures included under short-term debt
     419        1,779  
  
 
 
    
 
 
 
Total
   $ 16,357      $ 17,496  
  
 
 
    
 
 
 
 
*
The fair value was estimated based on quoted market prices.